Smart Money Is Betting Big In MRK Options - Merck & Co (NYSE:MRK)

Financial giants have made a conspicuous bearish move on Merck & Co. Our analysis of options history for Merck & Co (NYSE:MRK) revealed 9 unusual trades.

Delving into the details, we found 44% of traders were bullish, while 55% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $123,625, and 6 were calls, valued at $299,194.

Projected Price Targets

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $120.0 to $130.0 for Merck & Co during the past quarter.

Analyzing Volume & Open Interest

Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Merck & Co's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Merck & Co's substantial trades, within a strike price spectrum from $120.0 to $130.0 over the preceding 30 days.

Merck & Co Call and Put Volume: 30-Day Overview

Significant Options Trades Detected:

Symbol	PUT/CALL	Trade Type	Sentiment	Exp. Date	Ask	Bid	Price	Strike Price	Total Trade Price	Open Interest	Volume
MRK	CALL	SWEEP	BULLISH	07/26/24	$3.9	$3.7	$3.85	$124.00	$73.5K	443	214
MRK	CALL	SWEEP	BEARISH	08/02/24	$3.1	$3.0	$3.0	$127.00	$60.0K	300	226
MRK	CALL	SWEEP	BULLISH	09/20/24	$9.7	$9.7	$9.7	$120.00	$55.2K	1.9K	60
MRK	PUT	TRADE	BULLISH	07/26/24	$0.43	$0.33	$0.35	$125.00	$51.9K	1.6K	4.0K
MRK	CALL	SWEEP	BEARISH	08/02/24	$3.05	$3.0	$3.05	$127.00	$45.7K	300	193

About Merck & Co

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

After a thorough review of the options trading surrounding Merck & Co, we move to examine the company in more detail. This includes an assessment of its current market status and performance.

Present Market Standing of Merck & Co

Trading volume stands at 4,941,230, with MRK's price up by 0.4%, positioned at $126.42.
RSI indicators show the stock to be is currently neutral between overbought and oversold.
Earnings announcement expected in 5 days.

What The Experts Say On Merck & Co

A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $134.0.

An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on Merck & Co, which currently sits at a price target of $134.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Merck & Co with Benzinga Pro for real-time alerts.

MRKMerck & Co Inc

$111.400.02%

Overview

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.